Texas Tech's HemoBioTech

Searching for Texas Tech on Edgar, the SEC's online databese, I came across HemoBioTech.  Filings indicated Texas Tech owned over 800,000 shares, amounting to 5.8% of the company.  HemoBioTech was in the business of providing human blood substitutes.

Once the cash was drained from HemoBioTech, it ceased filing SEC reports.  None were filed in 2011 and 2012. 

One investor bet big on the firm in 2010.  He was:

The author of a new soon to be released investment book, "Finding Midas" "The Way to Mega Stock Gains."

I hope the book came out before HemoBioTechs' breakdown.I'm sure this is the exception to Texas Tech's investing prowess.  It was the only story available through the SEC.  Count it as a one off.